(6-Bromo-2-chloro-3-methylphenyl)boronic acid, 95.0%, 25g

1-(1-Ethoxyethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 95.0%, 1g

Work support ROTILABO®, 1 Piece

2,6-Difluoro-3-iodopyridine, 95.0%, 10g

(-)-BLEBBISTATIN, 95%, 100mg

3-isobutylmorpholine, 95.0%, 5g

BOC-HIS(3-ME)-OH, 97.0%, 1g

tert-Butyl 5-bromo-3,4-dihydroisoquinoline-2(1H)-carboxylate, 95.0%, 1g

Ethyl methanesulfonate, 99.0%, 500g

4-HYDROXY-8-METHOXY-2H-CHROMEN-2-ONE, 95%, 1g

(R)-1-(5-Bromopyridin-3-yl)ethanamine dihydrochloride, 95%, 100mg

Quinuclidine>96.0%(GC)(T)1g

E-Plan phase EPLPH S100x/1.25 oil immersion objective. Working distance 0.19 mm